Irritable Bowel Syndrome (IBS-D, diarrhoea-predominant)

Understanding diarrhoea-predominant IBS through community experiences and medical research.

Community experiences, not medical advice

What is IBS-D?

Irritable Bowel Syndrome with Diarrhoea (IBS-D) is a functional gastrointestinal disorder that affects the large intestine. It is characterized by abdominal pain, bloating, and frequent loose or watery bowel movements without an identifiable organic cause.

Rome IV describes IBS as a functional bowel disorder: tummy pain that keeps coming back, together with a change in how often you go or what your stool looks like. IBS-D is the pattern where diarrhoea is the main bowel-habit change. You can read the Rome IV bowel-disorders paper by Mearin, Lacy and colleagues on PubMed.

Common Symptoms

  • Abdominal pain and cramping, often relieved by bowel movements
  • Urgent need to have a bowel movement (urgency)
  • Loose, watery stools
  • Frequent bowel movements, especially in the morning or after meals
  • Bloating and gas
  • Feeling of incomplete evacuation after bowel movements
  • Mucus in the stool

Community Insights

Based on experiences shared in our community:

  • Many report significant improvement with dietary changes, particularly low-FODMAP approaches
  • Stress and anxiety are common triggers for symptom flare-ups
  • Approximately 62% have found success with anti-spasmodic medications for pain relief
  • Morning symptoms are particularly challenging for many members

Medical Research

Low-FODMAP diet in mixed IBS (Staudacher 2017)

Staudacher and colleagues randomised adults with IBS (Rome III; mixed subtypes, not IBS-D only) to a low-FODMAP diet or a sham diet. In the intention-to-treat analysis, 57% on the low-FODMAP diet reported adequate symptom relief versus 38% on the sham diet (p=0.051).

Gastroenterology 2017
View on PubMed

SeHCAT and bile acid diarrhoea in IBS-D

Wedlake and colleagues (2009) found SeHCAT retention below 10% in 32% of people with IBS-D-type symptoms (95% CI 29–35). Among those with SeHCAT below 10%, 80% responded to a bile acid binder. That 80% figure is the binder response at SeHCAT <10%, not “75% of IBS-D”. Guts UK describes bile acid diarrhoea as a condition that can be mistaken for IBS-D.

The AGA 2019 guideline (Smalley and colleagues) suggests testing for bile acid diarrhoea if you have chronic diarrhoea. That suggestion is conditional and based on low-quality evidence. In the UK the usual test is a SeHCAT scan.

Alimentary Pharmacology & Therapeutics 2009
View on PubMed View AGA 2019 on PubMed

CBT for refractory IBS (ACTIB)

The ACTIB trial (Everitt et al., Gut 2019) compared telephone-delivered and web-delivered CBT with treatment as usual in adults with refractory IBS — clinically significant symptoms for 12 months or more despite first-line therapies — not an IBS-D-only sample. Both CBT arms were superior to treatment as usual for IBS symptom severity and work and social adjustment at 12 months.

Gut 2019
View on PubMed

ACG 2021 — limited low-FODMAP trial and gut-directed psychotherapy

The ACG 2021 IBS guideline (Lacy and colleagues) recommends a limited trial of a low-FODMAP diet and suggests gut-directed psychotherapy — including gut-focused cognitive-behaviour therapy — for global IBS symptoms. If you try a short, dietitian-supported diet trial or CBT aimed at the gut, that is what this guideline suggests — not a guarantee.

American Journal of Gastroenterology 2021
View on PubMed

Approaches people discuss

These are options clinicians and guidelines discuss — not a self-treatment plan.

  • Established Ask whether bile acid diarrhoea could explain IBS-D-type diarrhoea. Guts UK notes bile acid diarrhoea can be mistaken for IBS-D. Wedlake and colleagues found low SeHCAT retention in about a third of IBS-D-type symptoms; AGA 2019 suggests testing for bile acid diarrhoea in chronic diarrhoea (conditional; low-quality evidence). In the UK the usual test is a SeHCAT scan. Binders are a clinician's call if bile acid diarrhoea is confirmed or strongly suspected — not DIY products. Sources: Guts UK; Wedlake PMID 19570102; AGA 2019 PMID 31302098.
  • Emerging A short, dietitian-supported limited low-FODMAP trial for global IBS symptoms, then reintroduction — not a forever restriction. Staudacher 2017 (mixed IBS, not IBS-D-only) and ACG 2021 support a limited trial; evidence quality is limited / very low. Sources: Staudacher PMID 28625832; ACG 2021 PMID 33315591; Monash University.
  • Established Gut-directed psychological care (including CBT aimed at the gut) when symptoms stay significant despite first-line care. ACTIB showed telephone- and web-delivered CBT better than treatment as usual in refractory IBS (not IBS-D-only). ACG 2021 suggests gut-directed psychotherapy for global IBS symptoms. Sources: ACTIB PMID 30971419; ACG 2021 PMID 33315591.
  • Limited Treating every IBS-D label as bile acid diarrhoea without a clinician's assessment; staying on strict low-FODMAP indefinitely without dietitian support; shopping for binders or US-only IBS-D medicines from a webpage.

Medical References

Mayo Clinic

Comprehensive overview of IBS-D symptoms, causes, diagnosis, and treatment options.

Visit Resource

International Foundation for Gastrointestinal Disorders

Patient-centered information on IBS-D, with resources for managing symptoms and finding support.

Visit Resource

Monash University FODMAP Resources

Evidence-based information on the low FODMAP diet, which has shown significant benefits for many IBS-D patients.

Visit Resource

Community Experiences with IBS-D

Real stories shared by our community members about managing diarrhoea-predominant IBS.

AH

Amanda H.

Living with IBS-D for 7+ years
"The low-FODMAP diet was a game-changer for me. After completing the elimination phase with a dietitian, I discovered that onions, garlic, and certain fruits were my biggest triggers. I also found that a daily probiotic (specifically Saccharomyces boulardii) helps regulate my digestion. For acute episodes, peppermint oil capsules provide quick relief from cramping and urgency."
Low-FODMAP Diet Probiotics Peppermint Oil Trigger Identification
RT

Robert T.

Managing IBS-D for 5 years
"Stress management has been the most important factor for me. I practice mindfulness meditation daily and use diaphragmatic breathing during flare-ups. I've also found that regular exercise—particularly yoga—helps regulate my gut function. Diet-wise, I avoid caffeine completely and limit alcohol to rare occasions. Soluble fiber supplements (psyllium husk) taken with plenty of water have helped firm up my stools."
Stress Management Yoga Caffeine Avoidance Soluble Fiber
CL

Christina L.

IBS-D for 10+ years
"After years of trial and error, I've found that a combination approach works best. I take a low-dose antispasmodic (dicyclomine) before meals that I know might be problematic. I've eliminated dairy completely and limit processed foods. Keeping a consistent meal schedule and never skipping meals has been crucial. I also use Imodium preventatively before situations where bathroom access might be limited."
Antispasmodics Dairy-Free Regular Meal Timing Preventative Medication